Logo image of PKI

PERKINELMER INC (PKI) Stock Fundamental Analysis

NYSE:PKI - New York Stock Exchange, Inc. - US7140461093 - Common Stock - Currency: USD

115.24  -1.06 (-0.91%)

After market: 115.24 0 (0%)

Fundamental Rating

5

Overall PKI gets a fundamental rating of 5 out of 10. We evaluated PKI against 56 industry peers in the Life Sciences Tools & Services industry. PKI has an excellent profitability rating, but there are some minor concerns on its financial health. PKI has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

9

1. Profitability

1.1 Basic Checks

PKI had positive earnings in the past year.
PKI had a positive operating cash flow in the past year.
In the past 5 years PKI has always been profitable.
Each year in the past 5 years PKI had a positive operating cash flow.
PKI Yearly Net Income VS EBIT VS OCF VS FCFPKI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 500M 1B

1.2 Ratios

With a decent Return On Assets value of 5.28%, PKI is doing good in the industry, outperforming 76.19% of the companies in the same industry.
The Return On Equity of PKI (10.11%) is better than 77.78% of its industry peers.
The Return On Invested Capital of PKI (6.49%) is better than 73.02% of its industry peers.
PKI had an Average Return On Invested Capital over the past 3 years of 52.37%. This is significantly above the industry average of 10.21%.
The 3 year average ROIC (52.37%) for PKI is well above the current ROIC(6.49%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 5.28%
ROE 10.11%
ROIC 6.49%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)52.37%
ROIC(5y)N/A
PKI Yearly ROA, ROE, ROICPKI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 5 10 15

1.3 Margins

The Profit Margin of PKI (16.32%) is better than 82.54% of its industry peers.
PKI's Profit Margin has improved in the last couple of years.
PKI's Operating Margin of 23.43% is amongst the best of the industry. PKI outperforms 88.89% of its industry peers.
In the last couple of years the Operating Margin of PKI has grown nicely.
The Gross Margin of PKI (58.39%) is better than 76.19% of its industry peers.
PKI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 23.43%
PM (TTM) 16.32%
GM 58.39%
OM growth 3Y19.66%
OM growth 5Y11.6%
PM growth 3Y29.61%
PM growth 5Y5.8%
GM growth 3Y7.46%
GM growth 5Y4.78%
PKI Yearly Profit, Operating, Gross MarginsPKI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 20 40 60

More info and screens

5

2. Health

2.1 Basic Checks

PKI has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
PKI has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for PKI has been reduced compared to a year ago.
PKI Yearly Shares OutstandingPKI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M
PKI Yearly Total Debt VS Total AssetsPKI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 5B 10B 15B

2.2 Solvency

An Altman-Z score of 2.51 indicates that PKI is not a great score, but indicates only limited risk for bankruptcy at the moment.
PKI has a Altman-Z score (2.51) which is comparable to the rest of the industry.
PKI has a debt to FCF ratio of 7.40. This is a slightly negative value and a sign of low solvency as PKI would need 7.40 years to pay back of all of its debts.
PKI has a better Debt to FCF ratio (7.40) than 77.78% of its industry peers.
PKI has a Debt/Equity ratio of 0.53. This is a neutral value indicating PKI is somewhat dependend on debt financing.
PKI's Debt to Equity ratio of 0.53 is on the low side compared to the rest of the industry. PKI is outperformed by 68.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 7.4
Altman-Z 2.51
ROIC/WACC0.65
WACC10.02%
PKI Yearly LT Debt VS Equity VS FCFPKI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2B 4B 6B

2.3 Liquidity

PKI has a Current Ratio of 2.13. This indicates that PKI is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.13, PKI is doing worse than 68.25% of the companies in the same industry.
A Quick Ratio of 1.87 indicates that PKI should not have too much problems paying its short term obligations.
PKI has a worse Quick ratio (1.87) than 65.08% of its industry peers.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 1.87
PKI Yearly Current Assets VS Current LiabilitesPKI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 1B 2B 3B

More info and screens

2

3. Growth

3.1 Past

The earnings per share for PKI have decreased strongly by -30.47% in the last year.
The Earnings Per Share has been growing by 22.15% on average over the past years. This is a very strong growth
Looking at the last year, PKI shows a decrease in Revenue. The Revenue has decreased by -3.37% in the last year.
The Revenue has been growing slightly by 7.97% on average over the past years.
EPS 1Y (TTM)-30.47%
EPS 3Y24.65%
EPS 5Y22.15%
EPS Q2Q%-33.59%
Revenue 1Y (TTM)-3.37%
Revenue growth 3Y4.72%
Revenue growth 5Y7.97%
Sales Q2Q%-27.89%

3.2 Future

The Earnings Per Share is expected to grow by 6.04% on average over the next years.
The Revenue is expected to decrease by -8.60% on average over the next years.
EPS Next Y-34.36%
EPS Next 2Y-12.79%
EPS Next 3Y-4.57%
EPS Next 5Y6.04%
Revenue Next Year-31.32%
Revenue Next 2Y-15.11%
Revenue Next 3Y-8.6%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PKI Yearly Revenue VS EstimatesPKI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B 5B
PKI Yearly EPS VS EstimatesPKI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 14.51, which indicates a correct valuation of PKI.
Based on the Price/Earnings ratio, PKI is valued cheaper than 96.83% of the companies in the same industry.
PKI is valuated cheaply when we compare the Price/Earnings ratio to 29.62, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 22.11, which indicates a rather expensive current valuation of PKI.
PKI's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. PKI is cheaper than 77.78% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of PKI to the average of the S&P500 Index (22.70), we can say PKI is valued inline with the index average.
Industry RankSector Rank
PE 14.51
Fwd PE 22.11
PKI Price Earnings VS Forward Price EarningsPKI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PKI indicates a rather cheap valuation: PKI is cheaper than 93.65% of the companies listed in the same industry.
PKI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. PKI is cheaper than 87.30% of the companies in the same industry.
Industry RankSector Rank
P/FCF 24.52
EV/EBITDA 12.35
PKI Per share dataPKI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

PKI has an outstanding profitability rating, which may justify a higher PE ratio.
PKI's earnings are expected to decrease with -4.57% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.66
EPS Next 2Y-12.79%
EPS Next 3Y-4.57%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PKI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PERKINELMER INC

NYSE:PKI (5/15/2023, 8:04:00 PM)

After market: 115.24 0 (0%)

115.24

-1.06 (-0.91%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)05-11 2023-05-11/bmo
Earnings (Next)07-31 2023-07-31/bmo
Inst Owners86.56%
Inst Owner Change-67.72%
Ins Owners0.81%
Ins Owner Change0%
Market Cap14.57B
Analysts73
Price Target159.39 (38.31%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP4.74%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.02%
Min EPS beat(2)2.33%
Max EPS beat(2)3.7%
EPS beat(4)4
Avg EPS beat(4)8.57%
Min EPS beat(4)2.33%
Max EPS beat(4)14.5%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-29.78%
Min Revenue beat(2)-30.42%
Max Revenue beat(2)-29.14%
Revenue beat(4)2
Avg Revenue beat(4)-0.3%
Min Revenue beat(4)-30.42%
Max Revenue beat(4)52.86%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.68%
PT rev (3m)-2.77%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-20.24%
EPS NY rev (1m)0%
EPS NY rev (3m)-13.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-17.56%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-11.39%
Valuation
Industry RankSector Rank
PE 14.51
Fwd PE 22.11
P/S 3.19
P/FCF 24.52
P/OCF 21.43
P/B 1.97
P/tB N/A
EV/EBITDA 12.35
EPS(TTM)7.94
EY6.89%
EPS(NY)5.21
Fwd EY4.52%
FCF(TTM)4.7
FCFY4.08%
OCF(TTM)5.38
OCFY4.67%
SpS36.16
BVpS58.4
TBVpS-19.59
PEG (NY)N/A
PEG (5Y)0.66
Profitability
Industry RankSector Rank
ROA 5.28%
ROE 10.11%
ROCE N/A
ROIC 6.49%
ROICexc 6.74%
ROICexgc 35.96%
OM 23.43%
PM (TTM) 16.32%
GM 58.39%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)52.37%
ROIC(5y)N/A
ROICexc(3y)8.57%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0.99%
ROICexcg growth 5Y-8%
ROICexc growth 3Y-3.25%
ROICexc growth 5Y0.67%
OM growth 3Y19.66%
OM growth 5Y11.6%
PM growth 3Y29.61%
PM growth 5Y5.8%
GM growth 3Y7.46%
GM growth 5Y4.78%
F-Score7
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 7.4
Debt/EBITDA 2.93
Cap/Depr 20.05%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 79.63%
Current Ratio 2.13
Quick Ratio 1.87
Altman-Z 2.51
F-Score7
WACC10.02%
ROIC/WACC0.65
Cap/Depr(3y)26.47%
Cap/Depr(5y)33.81%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)118.43%
Profit Quality(5y)114.16%
High Growth Momentum
Growth
EPS 1Y (TTM)-30.47%
EPS 3Y24.65%
EPS 5Y22.15%
EPS Q2Q%-33.59%
EPS Next Y-34.36%
EPS Next 2Y-12.79%
EPS Next 3Y-4.57%
EPS Next 5Y6.04%
Revenue 1Y (TTM)-3.37%
Revenue growth 3Y4.72%
Revenue growth 5Y7.97%
Sales Q2Q%-27.89%
Revenue Next Year-31.32%
Revenue Next 2Y-15.11%
Revenue Next 3Y-8.6%
Revenue Next 5YN/A
EBIT growth 1Y-24.58%
EBIT growth 3Y25.31%
EBIT growth 5Y20.49%
EBIT Next Year-23.7%
EBIT Next 3Y-3.21%
EBIT Next 5Y3.97%
FCF growth 1Y-54.67%
FCF growth 3Y28.17%
FCF growth 5Y18.96%
OCF growth 1Y-51.81%
OCF growth 3Y23.2%
OCF growth 5Y18.7%